Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Randomized Phase III Trial of Adjuvant Chemotherapy with or without Bevacizumab in Resected Non-Small Cell Lung Cancer (NSCLC): Results of E1505 Wakelee, H. A., Dahlberg, S. E., Keller, S. M., Tester, W. J., Gandara, D. R., Graziano, S. L., Adjei, A., Leighl, N., Aisner, S. C., Rothman, J. M., Patel, J., Sborov, M. D., Mcdermott, S. R., Perez-Soler, R., Traynor, A. M., Butts, C., Evans, T., Horn, L., Ramalingam, S. S., Schiller, J. ELSEVIER SCIENCE INC. 2015: S796
View details for Web of Science ID 000370365103677